10.4
Zevra Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−18.7
FY23:
−33.5
FY24:
−69.7
FY25:
−1.60
Change from FY21 to FY25
millions USD
FY21:
−15.5
FY22:
−36.7
FY23:
−17.4
FY24:
−22.2
FY25:
18.1
Change from FY21 to FY25
millions USD
FY21:
113
FY22:
8.35
FY23:
28.5
FY24:
82.1
FY25:
12.1
millions USD
FY21:
108
FY22:
−46.9
FY23:
−22.4
FY24:
−9.26
FY25:
28.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
10.3
FY22:
−18.8
FY23:
−33.8
FY24:
−69.7
FY25:
−2.43
All amounts in millions USD